Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Mohammed A. Aleskandarany(Nottingham University Hospitals NHS Trust), Emad A. Rakha(Nottingham City Hospital)
Cited by 126
Related Papers
Artificial intelligence in digital breast pathology: Techniques and applications
|The Breast|2019|200
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
|British Journal of Cancer|2016|125
Biological and clinical significance of PARP1 protein expression in breast cancer
|Breast Cancer Research and Treatment|2014|83
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
|British Journal of Cancer|2020|44